The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres
© Kanwar et al; licensee BioMed Central Ltd. 2010
Received: 16 February 2010
Accepted: 6 August 2010
Published: 6 August 2010
Recent evidence suggests that epithelial cancers, including colorectal cancer are driven by a small sub-population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which are thought to be responsible for recurrence of cancer. One of the characteristics of CSCs is their ability to form floating spheroids under anchorage-independent conditions in a serum-free defined media. The current investigation was undertaken to examine the role of Wnt/β-catenin pathway in regulating the growth and maintenance of colonospheres. Human colon cancer cells HCT-116 (p53 wild type; K-ras mutant), HCT-116 (p53 null; K-ras mutant) and HT-29 (p53 mutant) were used.
Colonospheres formed in vitro exhibited higher expression of colon CSCs markers LGR5, CD44, CD166 and Musashi-1 along with putative CSC marker EpCAM, compared to the corresponding parental cancer cells and also exhibit the ability to form spheroids under extreme limiting dilution, indicating the predominance of CSCs in colonospheres. Colonospheres formed by HCT-116 cells show over 80% of the cells to be CD44 positive, compared to ≤ 1% in the corresponding parental cells. Additionally, colonospheres showed reduced membrane bound β-catenin but had increased levels of total β-catenin, cyclin-D1 and c-myc and down regulation of axin-1 and phosphorylated β-catenin. Increased expression of β-catenin was associated with a marked transcriptional activation of TCF/LEF. The latter was greatly decreased following down regulation of β-catenin by the corresponding siRNA, leading to a marked reduction in CD44 positive cells as well as colonospheres formation. In contrast, upregulation of c-myc, a down-stream effector of TCF/LEF greatly augmented the formation of colonospheres.
Our data suggest that colonospheres formed by colon cancer cell lines are highly enriched in CSCs and that Wnt/β-catenin pathway plays a critical role in growth and maintenance of colonospheres.
A growing body of evidence supports the contention that epithelial cancers including the colorectal cancer are diseases driven by a small set of self renewing cells, termed cancer stem cells (CSC) or cancer-initiating cells, that are distinct from the bulk of the cells in the tumor . Initially identified in hematopoietic tumors, CSCs have now been identified and isolated in a variety of solid tumors that include breast, central nervous system, pancreas, skin, head and neck, colon and prostate [2–7]. CSCs share all the fundamental traits of stem cells-self renewal by asymmetric division, reduced proliferation and differentiation and resistance to apoptosis . CSCs are identified by specific surface epitopes, which in the colon include CD44, CD133 and CD166 [9, 10]. To select putative colorectal CSCs, a promising combination of three markers- EpCAM, CD44 and CD166 was described by Dalerba et al. . Although EpCAM previously being considered as pan-epithelial marker in the normal human colon, its frequent expression in CSCs in breast, colon, pancreas and prostate tumors suggests that this surface epitope could be a putative marker for CSCs, particularly in human colon cancer-derived cell lines . More recently Lgr5, Musashi-1 and aldehyde-dehydrogenase 1 (ALDH-1) have been added to the list of stem cell markers for colon cancer [13–15].
One of the recently reported characteristics of tumor derived CSCs is that they can be grown to form spherical colonies in vitro, when plated in limited numbers under anchorage-independent conditions in a serum-free defined media supplemented with growth factors . With the objectives to promoting in vitro expansions of CSCs, methods have been developed to grow and study them in sphere-forming assays as reported for neurospheres [16, 17], mammospheres [18, 19] and colonospheres [13, 20]. Using this approach, we and others have identified and/expanded colon CSCs by generating colonospheres from colon cancer cell lines [10, 21–24]. However, little is known about the signaling events that regulate the growth and maintenance of colonospheres.
Different signaling pathways such as Wnt, Hedgehog, Notch and Bmi have been implicated in various cellular processes during development that include differentiation, migration and proliferation [25–27]. Recent studies have reported the pivotal role of Wnt/β-catenin signaling pathway in the regulation of epithelial stem cell self renewal [28, 29]. In contrast, dysregulation of Wnt/β-catenin signaling has been implicated in colon carcinogenesis [30, 31]. However, the regulatory role of Wnt/β-catenin signaling in the maintenance and growth of colonospheres still remains elusive. The current investigation was, therefore, undertaken to study the in vitro expansion of colonospheres that display the characteristics of CSCs and to delineate the role of Wnt/β-catenin pathway in regulating the growth and maintenance of colonospheres using three different human colon cancer cells: HCT-116 (p53 wild-type; K-ras mutant), HCT-116 (p53 null; K-ras mutant) and HT-29 (p53 mutant, K-ras wild-type).
Generation and characterization of colonospheres
Extreme limiting dilution analysis of colonospheres forming frequency of HCT-116 cells, transfected with non-targeted (vector) or β-catenin siRNA and by colonospheres-derived cells
Number of cells/well
Number of wells plated
Number of wells showing colonospheres
Parental/β-catenin siRNA transfected
Sphere forming frequency (95% CI)
The Wnt/β-catenin pathway is activated in colonospheres
β-catenin is important for the generation of colonospheres
Recent studies have suggested that many epithelial cancers, including colon cancer arise from a small sub-population of CSCs through their oncogenic transformations [38–40]. There is a strong evidence that colon cancer-derived cell lines represent the tumors from which they are originally isolated  and can develop structures similar to those found in the original tissue , suggesting the presence of CSCs in colon cancer-derived cell lines. Much of the advance on CSCs comes from the assays that have used FACS technology to isolate and enrich for CSCs from primary tumors, and then testing their propagation in immune-deficient mice [20, 43]. Such assays are cumbersome and expensive, and do not readily enable either the characterization of CSCs or their functional properties. However, unlike the primary tumor, the cell lines represent a valuable resource that can be used repeatedly over time, and can be readily characterized by various CSCs assays. There are clearly many advantages to working with CSCs derived from cell lines, both for the possible development of novel targets for drug development, as well as for the possible development of relatively high-throughput drug-response assays for CSCs.
In the present work, using an approach to culture cells that display markers and characteristics of CSCs, we show that spheroid cultures (or colonospheres) generated from a limited number of human colon cancer-derived cell lines are enriched for cells that express colonic CSC markers. Widely accepted general characteristics of "stemness" include the expression of putative stem cell antigens, reduced cell cycle progression, and limited functional differentiation or dedifferentiation under the influence of the microenvironment [10, 44]. Currently, colon CSCs are defined by their expression of cell surface markers, such as Musashi, LGR-5, CD44, CD166, etc [11, 13–15]. Colonospheres generated under present conditions from the three different colon cancer lines show increased expression of colon CSCs markers along with pan-epithelial marker EpCAM, when compared with the corresponding parental cells. Additionally, the evidence for the presence of functional CSCs in colonospheres came from the ELDA that revealed a marked rise in frequency of sphere-forming ability of cells in colonospheres. Since under extreme limited dilution and in serum-free conditions (stem cell media), only stem-like cells are believed to divide to form spheroids, our observation of formation of colonospheres by a very small number of cells not only suggests the presence of functional CSCs in colon cancer derived cell line but also indicate the enrichment of CSCs in colonospheres [13, 20, 45].
CSCs have been shown to divide very slow and possess limited differentiation potential [10, 36]. The ratio between CSCs and differentiated cells has been suggested to depend on the rate of differentiation relative to the turnover rate of CSCs . In view of this, it is reasonable to suggest that lower the propensity to differentiate greater the proportion of CSCs. Recent reports have also demonstrated low functional differentiation potential of colon cancer cell lines that contain a high proportion of CSCs . Our current data demonstrate that colonospheres are poorly differentiated as evidenced by a marked reduction in alkaline phosphatase activity. Moreover, our observation that colonospheres also show increased H33342 efflux capabilities, accompanied by increased expression of ABC transporter protein ABCG2 suggests that they possess the ability to exclude drugs, a trait that has been demonstrated for CSCs [47, 48]. These observations and the fact that over 80% of colonospheres-derived cells are CD44 positive, a widely accepted colon CSC marker, and that the cells of colonospheres also show staining of EpCAM, which is believed to be a putative CSC marker in colon cancer cell lines, strongly indicate that colonospheres generated under present conditions are mainly composed of CSCs.
Increasing evidence suggests that many signaling pathways that are classically associated with cancer, including Wnt, Hedgehog, Notch and Bmi, may also regulate normal stem cell development. One particular interesting pathway that has also been shown to regulate both self-renewal of stem cell and oncogenesis in different organs is the Wnt signaling pathway . Wnt proteins regulate development in several organisms and contribute to cancer when dysregulated through the activation of β-catenin (a downstream activator of the Wnt signaling pathway). The canonical Wnt/β-catenin pathway has previously been reported to play a role in hematopoietic, mammary and brain stem cell functions [28, 49, 50]. The Wnt pathway is also a major regulator of stem cells in gastrointestinal system as identification of many different Wnt/β-catenin target genes have been implicated in intestinal stem cell proliferation and carcinogenesis . The best stemness-specific target of Wnt/β-catenin signaling known today is Lgr5 , while c-myc and cyclin-D1 are the other Wnt targets associated with proliferation of progenitor cells [29, 30]. Results derived from our current investigation suggest that Wnt/β-catenin pathway plays a critical role in regulating the growth and maintenance of colonospheres. Initial support for this inference comes from the observations that there is a marked loss of membrane bound β-catenin in colonosphere cells. Further, colonospheres formed by colon cancer HCT-116 (wt or p53-/-) and HT-29 show a marked reduction in the expression of phosphorylated form of β-catenin and axin-1 and increased levels of total β-catenin (non-phosphorylated form) and phosphorylated form of GSK-3β, compared to the corresponding controls. Moreover, to inactivate Wnt/β-catenin pathway by GSK-3β, axin is required for phosphorylation of β-catenin . The observed decrease in expression of axin-1 and β-catenin phosphorylation, therefore, suggests that the increased level of total β-catenin is due to the inhibition of β-catenin degradation. Increased levels of β-catenin, following translocation into the nucleus, is likely to cause induction of the TCF family of transcription factors leading to increased synthesis of several proteins that are critically involved in cellular growth . Indeed, our observation that colonospheres from HCT-116 wt and HT-29 cells shows higher levels of c-myc and cyclin-D1, compared to the corresponding parental cells, supports the contention that Wnt/β-catenin signaling plays a critical role in the formation of colonospheres. These findings were further corroborated by the observation that downregulation of β-catenin in the parent cell lines decreases the number of sphere-forming cells as demonstrated by ELDA. Furthermore, during serial passaging of colonospheres, downregulation of β-catenin causes reduction in CD44 positive cells and inhibition in transcriptional activation of TCF/LEF resulting in suppression of regeneration of secondary colonospheres formation. In contrast, overexpression of c-myc is associated with increased colonospheres formation. Taken together, the results strongly suggest that Wnt/β-catenin pathway has a pivotal role in the genesis, maintenance and expansion of CSCs enriched spheroid cultures.
In conclusion, our data demonstrate that colonospheres formed by colon cancer cells are predominantly composed of cells displaying the characteristics of CSCs. Wnt/β-catenin signaling plays a pivotal role in the growth and maintenance of colonospheres in that downregulation of β-catenin that decreases TCF/LEF transcriptional activity resulting in reduction of CD44 positive cells leading to a marked suppression of colonosphere formation and regeneration. In contrast, overexpression of c-myc, a downstream effector of Wnt/β-catenin signaling, reverses the situation. We suggest that the colonosphere formation technique is a useful in vitro method to enrich cultures for CSCs or as a surrogate for tumor formation. The data presented in this communication also provide a basis for identification of distinctive molecular pathway(s) for self-renewal of CSCs and for the growth and maintenance of colonospheres.
Cell lines and culture conditions
The human colon cancer cells HCT-116 (p53 wild type; K-ras mutant), HCT-116 (p53 null; K-ras mutant) and HT-29 (p53 mutant; K-ras wt) were obtained from the American Type Culture Collection (ATCC, Rockville, MD). Cells were maintained in Dulbecco's modified Eagle medium (DMEM; 4.5 g/L d-glucose) supplemented with 10% FBS and 1% antibiotic/antimycotic in tissue culture flasks in a humidified incubator at 37°C in an atmosphere of 95% air and 5% carbon dioxide. The medium was changed twice a week, and the cells were passaged using 0.05% trypsin/EDTA.
Antibodies used for immunofluorescence, or Western blotting were as follows: rabbit anti-LGR5/GPR49 (Abgent, San Diego, CA), mouse anti-β-actin (Chemicon International, Billerica, MA), mouse anti-CD44 (Abcam Inc., Cambridge, MA), rabbit anti-Musashi-1 (Imgenex, San Diego, CA), mouse anti-cyclin-D1, rabbit anti-ABCG2, mouse anti-β-catenin (Santa Cruz Biotechnology Inc., Santa Cruz, CA); rabbit anti-c-myc, mouse anti-EpCAM, mouse anti-CD44, rabbit anti-axin1, rabbit anti-phospho-β-catenin, Cell Signaling, Danvers, MA) and FITC-conjugated mouse-IgG2b (Sigma-Aldrich Inc, St Louis, MO). Mouse anti-human PerCP-Cy5 IgG2b (isotype) or CD44 conjugated antibodies (Santa Cruz Biotechnology Inc., Santa Cruz, CA) and mouse anti-human PE-Cy7 IgG2b (isotype) or CD44 conjugated antibodies (BD Pharmingen) were used for flow cytometry.
For all Western blot analyses, protein was harvested from adherent cells and colonospheres. Cell lysates were prepared by homogenizing the cells in lysis buffer as previously described . Quantification of the proteins was carried out using a modified Bradford assay (Bio-Rad Laboratories). Protein samples for Western blotting were prepared by boiling after the addition of denaturing sample buffer. Proteins were separated using SDS-PAGE on an 8% or 15% gel and transferred to a polyvinylidene difluoride membrane (Millipore) by electroblotting. Antibodies were diluted in TBS and 0.1% (v/v) Tween with 5% nonfat dry milk after 1 h of protein blocking in the absence of antibodies. Membranes were incubated at 4°C overnight with the primary antibody, subsequently washed and incubated with the appropriate horseradish peroxidase-conjugated secondary antibody (Amersham Biosciences) for 1 h at room temperature. Membranes were again washed, and protein bands were visualized using a commercially available enhanced chemiluminescence kit (Amersham Biosciences). When appropriate, membranes were incubated in stripping solution for 30 min at 65°C, washed, and re-probed with a second primary antibody for verification of loading control.
Formation of colonospheres
The ability of cell lines to form spheres in suspension was evaluated as described by Liu et al. , with slight modifications. Briefly, primary colonospheres were generated by incubating the limited number of parental HCT-116 (p53 wild-type; K-ras mutant), HCT-116 (p53 null; K-ras mutant) and HT-29 (p53 mutant; K-ras wild-type) cells at a concentration of 100 cells per 200 μL in serum-free stem cell medium (SCM) containing DMEM/F12 (1:1) supplemented with B27 (Life Technologies, Gaithersburg, MD), 20 ng/ml EGF (Sigma, St Louis, MO), 10 ng/ml fibroblast growth factor (Sigma), and antibiotic-anti-mycotic in 24-well ultra low-attachment plates (Corning Inc, Lowell, MA) for 10 days. The colonospheres formed at the end of the incubation period were centrifuged (1000 rpm), dissociated with 0.05% trypsin/EDTA using a 22 gauge needle and then passed through a 40 μM sieve to obtain single cell suspension, as described by Kakarala et al. . The single-cell suspension derived from colonospheres that have undergone 15 or more serial passages were used for all experiments. For spheroids formation, an equal number of cells from adherent cell lines and colonospheres cells were plated at 200 cells/100 μL SCM in each 96 ultra low-attachment well (Corning Inc, Lowell, MA). The colonospheres formed after 5 days were evaluated for their number and size by light microscopy.
Extreme limiting dilution analysis
Extreme limiting dilution analysis (ELDA) was performed as described by Hu and Smyth . Briefly, single cell suspension obtained from adherent or colonospheres-derived cells were plated at concentration of 1000, 100, 10 cells and 1 cell per 100 μl SCM (24 well for each dilution) in 96-well ultra-low attachment and incubated for 5 days. At the end of 5 days, the number of wells showing formation of colonospheres was counted. The frequency of sphere forming cells in a particular cell type was determined using ELDA webtool at http://bioinf.wehi.edu.au/software/elda.
Flow Cytometry Analysis
Single cell suspension from parental monolayer cell cultures and colonospheres were subjected to direct immunofluorescence staining followed by flow cytometry analysis according to our standard protocol . Briefly, the cells were harvested and washed with PBS. Half a million cells were suspended in 90 μl of PBS containing 0.5% BSA. After 10 min at room temperature, 10 μl of fluorophore conjugated anti-human CD44 antibody was added and incubated for 30 min in dark at room temperature. The samples were then washed and analyzed using a FACS DiVa (BD, San Jose, CA). The cells stained with mouse IgG2b (isotype-negative control) served as gating control. The proportion of CD44 positive cells was determined on the basis of fluorescence intensity-spectra of CD44-conjugated PE-Cy7 or PerCP-Cy5.
Single cell suspension, obtained from parental and colonosphere, was washed in PBS and fixed in 2-4% formaldehyde for 10 min at 37 °C. They were washed and re-suspended in 0.5% BSA-PBS (blocking buffer) for 10 min, subsequently incubated in primary antibodies at appropriate dilution for 1 h at room temperature. After rinsing with incubation buffer, the cells were resuspended in fluorophore-conjugated secondary antibodies diluted in incubation buffer according to the manufacturer's recommendations and incubated for 30 minutes at room temperature. The cells were then resuspended in PBS after washing with the incubation buffer. Appropriate aliquot of cells were mounted on glass slides immediately before examining under fluorescence microscope.
Hoechst 33342 dye exclusion assay
Single cell suspension obtained from parental cell lines and colonospheres were washed with PBS (3 times) and stained with Hoechst 33342 or H342 (5 μg/ml, Sigma-Aldrich Inc, St Louis, MO) for 45 minutes at 37°C in HBSS buffer, vortexing gently every 15 min. As a control, a sample was treated with verapamil (Sigma, 50 μM) for ten minutes at room temperature prior to the addition of H342. The stained cells were collected, washed with PBS and resuspended in 3 ml of PBS containing 2 μg/ml of propidium iodide, and subsequently analyzed by flow cytometer-FACS Vantage SE/DiVa SORP (BD Biosciences, San Jose, CA) with all-digital electronics and octagon- and trigon-shaped detector arrays. Excitation of 100 mW at 488 nm was provided by a 177-G argon ion laser (Spectra-Physics, Mountain View, CA) and 200 mW of all-lines UV (351-365 nm) was provided by an Innova 90-5 argon ion laser (Coherent, Palo Alto, CA). Forward and side laser scatter was detected from 488 nm excitation. H342 and propidium iodide fluorescence from UV excitation was split into "blue" and "red" wavelengths by a 505 nm long pass dichroic with a 450/50 bandpass (425-475 nm) filter in front of the "blue" detector and a 630 nm long pass filter in front of the "red" detector. Cell population showing H342 Bright (H342Br) and H342 Low (H342Lo) was determined and the ratio of H342Lo/H3342Br was calculated to evaluate the dye-efflux capacities of the cells. The gating of H342Lo and H342Br cells was based on a verapamil control. Dead cells were gated out based on positive staining with propidium iodide.
Determination of cellular growth
Changes in cellular growth, an assessment of proliferation, of parental and colonosphere-derived cells were assessed by 3-(4, 5-dimethylthiazol-2yl)-2, 5-diphenyltetrazolium bromide (MTT) assay as described previously . Briefly, 4000 cells were plated per well in 96-well plates in 200 μl medium. At each time point (0, 24, 48, 72, 96, 120 h), 20 μl MTT solution was added to each well and the plate was incubated for 1 h at 37°C. Medium was then aspirated from each well, and 100 μl DMSO was added. The intensity of the color developed, which is the reflection of number of live cells, was measured at a wavelength of 570 nm. All values were compared to the corresponding controls. All assays were performed with 6 replicates.
Measurement of Alkaline phosphatase activity
Status of differentiation was determined by measuring the alkaline phosphatase activity using SensoLyte, pNPP alkaline phosphatase assay kit (Anaspec, San Jose, CA) according to the manufacturer's instructions and measuring the absorbance at 405 nm.
β-catenin siRNA transfection
For the transfection of siRNA into the parental and colonosphere derived cells, Oligofectamine reagent (Invitrogen Corp., Carlsbad, CA) and serum-free Opti-MEM (Invitrogen Corp., Carlsbad, CA) medium was used to prepare transfection complexes according to the manufacturer's instructions. Briefly, single cell suspension of colonospheres was plated in 10 cm tissue culture plates with normal growth medium overnight to achieve 25-30% confluence. Next day the medium was removed, washed twice with serum-free Opti-MEM (Invitrogen Corp., Carlsbad, CA) medium prior to adding the complexes containing non-targeted or β-catenin siRNA (Integrated DNA Technologies Inc., Coralville, IA). After 3 days of transfection, the cells were collected and analyzed for protein expression of β-catenin using Western blot and for colonosphere formation assay using SCM.
Activation of relative TCF/LEF-Dual Luciferase assay
The activation of transcription factor TCF/LEF was evaluated by using Cignal TCF/LEF reporter assay kit (SA Biosciences, Frederick, MD). The cells were grown to 25-30% confluence as described above and co-transfected with TCF/LEF reporter constructs and either non-targeted or β-catenin siRNAs (Integrated DNA Technologies Inc., Coralville, IA) using SureFECT transfection reagent (SA Biosciences, Frederick, MD) according to manufacturer's instructions. The TCF/LEF reporter used a mixture of an inducible β-catenin-responsive luciferase construct and a constitutively expressing Renilla element (40:1). At the end of 16-24 h incubation period Opti-MEM medium was changed to DMEM 10% FBS for parental cell lines or SCM for colonosphere derived cells. The cells were allowed to grow for another 3 days, collected and analyzed for TCF/LEF activity using a dual-luciferase assay kit (Promega-Biosciences, San Luis Obispo, CA) following the instructions outlined by the manufacturer.
Overexpression of c-myc gene
Single cell suspension of HCT-116 parental cells was plated in the tissue culture plates to achieve a 90% confluence. Once the 90% confluence is achieved, the adherent cells were transfected using Lipofectamine 2000 and PLUS reagent (Invitrogen Corp., Carlsbad, CA) with plasmid vector-pCMV6-Neo (Origene, Rockville, MD) containing human cDNA clone for c-myc gene or empty plasmid PCMV6-vector in OPTI-MEM medium according to the manufacturer's instruction. After 3 days of transfection, the cells were analyzed for c-myc protein expression by Western blot and re-plated for colonosphere formation assay.
Unless otherwise stated, data are expressed as mean ± SD of six observations. Where applicable, the results were analyzed using analysis of variance followed by Fisher protected least significant differences or Scheffé test. p < 0.01 was designated as the level of significance.
Shailender S. Kanwar, Ph.D.: Postdoctoral Research Fellow, Department of Internal Medicine and Veterans Affairs Medical Center, Wayne State University, Detroit, MI 48201, USA. E-mail: firstname.lastname@example.org
Yingjie Yu, M.D., Research Assistant Professor, Department of Internal Medicine and Veterans Affairs Medical Center, Wayne State University, Detroit, MI 48201, USA. E-mail: email@example.com
Jyoti Nautiyal, Ph.D.: Postdoctoral Research Fellow, Department of Internal Medicine and Veterans Affairs Medical Center, Wayne State University, Detroit, MI 48201, USA. E-mail: firstname.lastname@example.org
Bhaumik B. Patel, M.D.: Staff Oncologist and Assistant Professor, Department of Internal Medicine, Veterans Affairs Medical Center and Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. E-mail: email@example.com
Adhip P.N. Majumdar, Ph.D., D.Sc.: Professor and Senior Research Career Scientist, Department of Internal Medicine, Veterans Affairs Medical Center and Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA. E-mail: firstname.lastname@example.org
This work was supported by grants (APNM) from the National Institutes of Health/National Institute on Aging (AG014343) and the Department of Veterans Affairs.
- Jordan CT, Guzman ML, Noble M: Cancer stem cells. N Engl J Med. 2006, 355: 1253-1261. 10.1056/NEJMra061808View ArticlePubMed
- Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997, 3: 730-737. 10.1038/nm0797-730View ArticlePubMed
- Jimeno A, Feldmann G, Suárez-Gauthier A, Rasheed Z, Solomon A, Zou G-M, Rubio-Viqueira B, García-García E, López-Ríos F, Matsui W: A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Molecular Cancer Therapeutics. 2009, 8: 310-314. 10.1158/1535-7163.MCT-08-0924PubMed CentralView ArticlePubMed
- Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ: Efficient tumour formation by single human melanoma cells. Nature. 2008, 456: 593-598. 10.1038/nature07567PubMed CentralView ArticlePubMed
- Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS, Prince ME: Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head & Neck. 2010, 9999:
- Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010, 12: 468-476. 10.1038/ncb2048View ArticlePubMed
- Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass SA, Jiang F: ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients/' outcome. Lab Invest. 2009, 90: 234-244. 10.1038/labinvest.2009.127PubMed CentralView ArticlePubMed
- Dick JE: Stem cell concepts renew cancer research. Blood. 2008, 112: 4793-4807. 10.1182/blood-2008-08-077941View ArticlePubMed
- Sukach A, Ivanov E: Formation of spherical colonies as a property of stem cells. Cell and Tissue Biology. 2007, 1: 476-481. 10.1134/S1990519X07060028.View Article
- Yeung TM, Gandhi SC, Wilding JL, Muschel R, Bodmer WF: Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA. 2010, 107: 3722-3727. 10.1073/pnas.0915135107PubMed CentralView ArticlePubMed
- Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA. 2007, 104: 10158-10163. 10.1073/pnas.0703478104PubMed CentralView ArticlePubMed
- Gires O, Klein CA, Baeuerle PA: On the abundance of EpCAM on cancer stem cells. Nat Rev Cancer. 2009, 9: 143-143. 10.1038/nrc2499-c1View ArticlePubMed
- Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, Perez Alea M, Richel DJ, Stassi G, Medema JP: Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA. 2008, 105: 13427-13432. 10.1073/pnas.0805706105PubMed CentralView ArticlePubMed
- Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M: Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med. 2008, 14: 450-460. 10.1016/j.molmed.2008.08.003View ArticlePubMed
- Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009, 69: 3382-3389. 10.1158/0008-5472.CAN-08-4418PubMed CentralView ArticlePubMed
- Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, Caldwell MA: A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods. 1998, 85: 141-152. 10.1016/S0165-0270(98)00126-5View ArticlePubMed
- Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63: 5821-5828.PubMed
- Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, Anderson NG, Bundred NJ: Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst. 2007, 99: 616-627. 10.1093/jnci/djk133View ArticlePubMed
- Kakarala M, Brenner D, Korkaya H, Cheng C, Tazi K, Ginestier C, Liu S, Dontu G, Wicha M: Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Research and Treatment. 2010, 122: 777-785. 10.1007/s10549-009-0612-xPubMed CentralView ArticlePubMed
- Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature. 2007, 445: 111-115. 10.1038/nature05384View ArticlePubMed
- Dallas NA, Xia L, Fan F, Gray MJ, Gaur P, van Buren G, Samuel S, Kim MP, Lim SJ, Ellis LM: Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 2009, 69: 1951-1957. 10.1158/0008-5472.CAN-08-2023PubMed CentralView ArticlePubMed
- Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, Majumdar APN: Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Translational Oncology. 2009, 2: 321-328.PubMed CentralView ArticlePubMed
- Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI: Phenotypic Subpopulations of Metastatic Colon Cancer Stem Cells: Genomic Analysis. Cancer Genomics - Proteomics. 2009, 6: 19-29.PubMed
- Weiswald LB, Guinebretiere JM, Richon S, Bellet D, Saubamea B, Dangles-Marie V: In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy. BMC Cancer. 2010, 10: 106- 10.1186/1471-2407-10-106PubMed CentralView ArticlePubMed
- Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006, 66: 6063-6071. 10.1158/0008-5472.CAN-06-0054PubMed CentralView ArticlePubMed
- Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM, Wicha MS: Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res. 2004, 6: R605-615. 10.1186/bcr920PubMed CentralView ArticlePubMed
- Lowry WE, Blanpain C, Nowak JA, Guasch G, Lewis L, Fuchs E: Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes Dev. 2005, 19: 1596-1611. 10.1101/gad.1324905PubMed CentralView ArticlePubMed
- Korkaya H, Paulson A, Charafe-Jauffret E, Ginestier C, Brown M, Dutcher J, Clouthier SG, Wicha MS: Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol. 2009, 7: e1000121- 10.1371/journal.pbio.1000121PubMed CentralView ArticlePubMed
- Brabletz S, Schmalhofer O, Brabletz T: Gastrointestinal stem cells in development and cancer. J Pathol. 2009, 217: 307-317. 10.1002/path.2475View ArticlePubMed
- Kolligs FT, Bommer G, Goke B: Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion. 2002, 66: 131-144. 10.1159/000066755View ArticlePubMed
- Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997, 275: 1787-1790. 10.1126/science.275.5307.1787View ArticlePubMed
- Ricci-Vitiani L, Pagliuca A, Palio E, Zeuner A, De Maria R: Colon cancer stem cells. Gut. 2008, 57: 538-548. 10.1136/gut.2007.127837View ArticlePubMed
- Patel VB, Yu Y, Das JK, Patel BB, Majumdar APN: Schlafen-3: A novel regulator of intestinal differentiation. Biochemical and Biophysical Research Communications. 2009, 388: 752-756. 10.1016/j.bbrc.2009.08.094PubMed CentralView ArticlePubMed
- Fletcher JI, Haber M, Henderson MJ, Norris MD: ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010, 10: 147-156. 10.1038/nrc2789View ArticlePubMed
- Scharenberg CW, Harkey MA, Torok-Storb B: The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood. 2002, 99: 507-512. 10.1182/blood.V99.2.507View ArticlePubMed
- Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature. 2001, 414: 105-111. 10.1038/35102167View ArticlePubMed
- Ishimoto T, Oshima H, Oshima M, Kai K, Torii R, Masuko T, Baba H, Saya H, Nagano O: CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis. Cancer Sci. 2010, 101: 673-678. 10.1111/j.1349-7006.2009.01430.xView ArticlePubMed
- Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M: A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas. Cancer Res. 2005, 65: 9328-9337. 10.1158/0008-5472.CAN-05-1343View ArticlePubMed
- Lawson DA, Witte ON: Stem cells in prostate cancer initiation and progression. The Journal of Clinical Investigation. 2007, 117: 2044-2050. 10.1172/JCI32810PubMed CentralView ArticlePubMed
- Levi E, Misra S, Du J, Patel BB, Majumdar AP: Combination of aging and dimethylhydrazine treatment causes an increase in cancer-stem cell population of rat colonic crypts. Biochem Biophys Res Commun. 2009, 385: 430-433. 10.1016/j.bbrc.2009.05.080PubMed CentralView ArticlePubMed
- Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, Bodmer W, Tomlinson IP, Carter NP: Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res. 2004, 64: 4817-4825. 10.1158/0008-5472.CAN-04-0328View ArticlePubMed
- Willson JK, Bittner GN, Oberley TD, Meisner LF, Weese JL: Cell culture of human colon adenomas and carcinomas. Cancer Res. 1987, 47: 2704-2713.PubMed
- O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007, 445: 106-110. 10.1038/nature05372View ArticlePubMed
- Zenali MJ, Tan D, Li W, Dhingra S, Brown RE: Stemness Characteristics of Fibrolamellar Hepatocellular Carcinoma: Immunohistochemical Analysis with Comparisons to Conventional Hepatocellular Carcinoma. Ann Clin Lab Sci. 2010, 40: 126-134.PubMed
- Hu Y, Smyth GK: ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009, 347: 70-78. 10.1016/j.jim.2009.06.008View ArticlePubMed
- Johnston MD, Edwards CM, Bodmer WF, Maini PK, Chapman SJ: Examples of mathematical modeling: tales from the crypt. Cell Cycle. 2007, 6: 2106-2112. 10.4161/cc.6.17.4649PubMed CentralView ArticlePubMed
- Christgen M, Ballmaier M, Bruchhardt H, von Wasielewski R, Kreipe H, Lehmann U: Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line. Molecular and Cellular Biochemistry. 2007, 306: 201-212. 10.1007/s11010-007-9570-yView ArticlePubMed
- Miele L, Takebe N, Ivy SP: The Cancer Stem Cell Hypothesis, Embryonic Signaling Pathways, and Therapeutics: Targeting an Elusive Concept. ASCO EDUCATIONAL BOOK. 2009, 2009: 145-156.
- Staal Frank JT, Sen JM: The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis. European Journal of Immunology. 2008, 38: 1788-1794. 10.1002/eji.200738118PubMed CentralView ArticlePubMed
- Pu P, Zhang Z, Kang C, Jiang R, Jia Z, Wang G, Jiang H: Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther. 2009, 16: 351-361. 10.1038/cgt.2008.78View ArticlePubMed
- Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H, van den Born M: Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 2010, 6: 25-36. 10.1016/j.stem.2009.11.013View ArticlePubMed
- Ricci-Vitiani L, Fabrizi E, Palio E, De Maria R: Colon cancer stem cells. Journal of Molecular Medicine. 2009, 87: 1097-1104. 10.1007/s00109-009-0518-4View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.